These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31818443)

  • 21. Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry.
    Alonso R; Díaz-Díaz JL; Arrieta F; Fuentes-Jiménez F; de Andrés R; Saenz P; Ariceta G; Vidal-Pardo JI; Almagro F; Argueso R; Prieto-Matos P; Miramontes JP; Pintó X; Rodriguez-Urrego J; Perez de Isla L; Mata P
    J Clin Lipidol; 2016; 10(4):953-961. PubMed ID: 27578128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry).
    Kayikcioglu M; Tokgozoglu L; Yilmaz M; Kaynar L; Aktan M; Durmuş RB; Gokce C; Temizhan A; Ozcebe OI; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Yenercag M; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O
    Atherosclerosis; 2018 Mar; 270():42-48. PubMed ID: 29407887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homozygous familial hypercholesterolemia and its management.
    Marais AD; Firth JC; Blom DJ
    Semin Vasc Med; 2004 Feb; 4(1):43-50. PubMed ID: 15199432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel.
    Al-Ashwal A; Alnouri F; Sabbour H; Al-Mahfouz A; Al-Sayed N; Razzaghy-Azar M; Al-Allaf F; Al-Waili K; Banerjee Y; Genest J; Santos RD; Al-Rasadi K
    Curr Vasc Pharmacol; 2015; 13(6):759-70. PubMed ID: 26311574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial hypercholesterolaemia.
    Nair DR; Sharifi M; Al-Rasadi K
    Curr Opin Cardiol; 2014 Jul; 29(4):381-8. PubMed ID: 24870549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Atherosclerosis; 2018 Mar; 270():26-32. PubMed ID: 29407885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the characteristics of patients and their clinical management on outcomes in children with homozygous familial hypercholesterolemia.
    Al-Shaikh AM; Abdullah MH; Barclay A; Cullen-Dean G; McCrindle BW
    Cardiol Young; 2002 Mar; 12(2):105-12. PubMed ID: 12018713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia.
    Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L
    J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
    Vishwanath R; Hemphill LC
    J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide.
    Roeters van Lennep J; Averna M; Alonso R
    J Clin Lipidol; 2015; 9(4):607-17. PubMed ID: 26228681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of coronary flow velocity reserve in homozygous familial hypercholesterolemia by transthoracic Doppler echocardiography and dual-source computed tomography.
    Yang Y; Zhang X; Li R; Ren H; Wang Z; Li Z; Lin J; Wang L; Yu W; Zhang Z
    Ultrasound Med Biol; 2010 Oct; 36(10):1756-61. PubMed ID: 20800956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of LDL apheresis in a case of homozygous familial hypercholesterolemia.
    Naveen T; Biswas A; Wig N; Soneja M; Jorwal P; Durga CS; Singla P; Chaudhary C; Baitha U
    Drug Discov Ther; 2019; 13(1):59-61. PubMed ID: 30880324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Four-year imaging follow-up of a homozygous familial hypercholesterolaemia patient: atherosclerosis ingravescence and coronary flow velocity reserve reduced gradually. Case report.
    Jiang B; Yang Y; Wang L; Gao F; Jiao J; Li R
    Med Ultrason; 2015 Sep; 17(3):401-3. PubMed ID: 26343092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daily life, experience and needs of persons suffering from homozygous familial hypercholesterolaemia: insights from a patient survey.
    Bruckert E; Saheb S; Bonté JR; Coudray-Omnès C
    Atheroscler Suppl; 2014 Sep; 15(2):46-51. PubMed ID: 25257076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis and effective therapy with plasmapheresis in a patient with homozygous familial hypercholesterolemia].
    Widhalm K; Kleinberger G; Strobl W; Pachinger O; Kaliman J
    Helv Paediatr Acta; 1984 May; 39(2):153-60. PubMed ID: 6543838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia.
    Ito MK; Watts GF
    Drugs; 2015 Oct; 75(15):1715-24. PubMed ID: 26370207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations.
    Stein EA; Dann EJ; Wiegman A; Skovby F; Gaudet D; Sokal E; Charng MJ; Mohamed M; Luirink I; Raichlen JS; Sundén M; Carlsson SC; Raal FJ; Kastelein JJP
    J Am Coll Cardiol; 2017 Aug; 70(9):1162-1170. PubMed ID: 28838366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia.
    Blom DJ; Cuchel M; Ager M; Phillips H
    Orphanet J Rare Dis; 2018 Jun; 13(1):96. PubMed ID: 29925433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
    ; Vallejo-Vaz AJ; De Marco M; Stevens CAT; Akram A; Freiberger T; Hovingh GK; Kastelein JJP; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Al-Khnifsawi M; AlKindi FA; Alnouri F; Alonso R; Al-Rasadi K; Al-Sarraf A; Ashavaid TF; Binder CJ; Bogsrud MP; Bourbon M; Bruckert E; Chlebus K; Corral P; Descamps O; Durst R; Ezhov M; Fras Z; Genest J; Groselj U; Harada-Shiba M; Kayikcioglu M; Lalic K; Lam CSP; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi HM; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Postadzhiyan A; Reda A; Reiner Ž; Sadoh WE; Sahebkar A; Shehab A; Shek AB; Stoll M; Su TC; Subramaniam T; Susekov AV; Symeonides P; Tilney M; Tomlinson B; Truong TH; Tselepis AD; Tybjærg-Hansen A; Vázquez-Cárdenas A; Viigimaa M; Vohnout B; Widén E; Yamashita S; Banach M; Gaita D; Jiang L; Nilsson L; Santos LE; Schunkert H; Tokgözoğlu L; Car J; Catapano AL; Ray KK;
    Atherosclerosis; 2018 Oct; 277():234-255. PubMed ID: 30270054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.